ID PTPRM_HUMAN Reviewed; 1452 AA. AC P28827; A7MBN1; D3DUH8; J3QL11; DT 01-DEC-1992, integrated into UniProtKB/Swiss-Prot. DT 23-SEP-2008, sequence version 2. DT 27-MAR-2024, entry version 230. DE RecName: Full=Receptor-type tyrosine-protein phosphatase mu; DE Short=Protein-tyrosine phosphatase mu; DE Short=R-PTP-mu; DE EC=3.1.3.48; DE Flags: Precursor; GN Name=PTPRM; Synonyms=PTPRL1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=1655529; DOI=10.1016/0014-5793(91)81241-y; RA Gebbink M.F.B.G., van Etten I., Hateboer G., Suijkerbuijk R., RA Beijersbergen R., Geurts van Kessel A., Moolenaar W.H.; RT "Cloning, expression and chromosomal localization of a new putative RT receptor-like protein tyrosine phosphatase."; RL FEBS Lett. 290:123-130(1991). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16177791; DOI=10.1038/nature03983; RA Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D., RA Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., RA Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J., RA Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L., RA Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., RA Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., RA Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K., RA Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R., RA Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.; RT "DNA sequence and analysis of human chromosome 18."; RL Nature 437:551-555(2005). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION. RX PubMed=10753936; DOI=10.1074/jbc.275.15.11264; RA Zondag G.C., Reynolds A.B., Moolenaar W.H.; RT "Receptor protein-tyrosine phosphatase RPTPmu binds to and dephosphorylates RT the catenin p120(ctn)."; RL J. Biol. Chem. 275:11264-11269(2000). RN [6] RP GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-131. RC TISSUE=Plasma; RX PubMed=16335952; DOI=10.1021/pr0502065; RA Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J., RA Smith R.D.; RT "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, RT hydrazide chemistry, and mass spectrometry."; RL J. Proteome Res. 4:2070-2080(2005). RN [7] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-821, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Cervix carcinoma; RX PubMed=18669648; DOI=10.1073/pnas.0805139105; RA Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., RA Elledge S.J., Gygi S.P.; RT "A quantitative atlas of mitotic phosphorylation."; RL Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). RN [8] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 879-1156. RX PubMed=9346878; DOI=10.1074/jbc.272.44.27505; RA Hoffmann K.M., Tonks N.K., Barford D.; RT "The crystal structure of domain 1 of receptor protein-tyrosine phosphatase RT mu."; RL J. Biol. Chem. 272:27505-27508(1997). RN [9] RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=21998202; DOI=10.1091/mbc.e11-03-0175; RA Kim W.K., Jung H., Kim E.Y., Kim D.H., Cho Y.S., Park B.C., Park S.G., RA Ko Y., Bae K.H., Lee S.C.; RT "RPTPmu tyrosine phosphatase promotes adipogenic differentiation via RT modulation of p120 catenin phosphorylation."; RL Mol. Biol. Cell 22:4883-4891(2011). RN [10] RP X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 21-279, FUNCTION, AND DISULFIDE RP BONDS. RX PubMed=16456543; DOI=10.1038/sj.emboj.7600974; RA Aricescu A.R., Hon W.-C., Siebold C., Lu W., van der Merwe P.A., RA Jones E.Y.; RT "Molecular analysis of receptor protein tyrosine phosphatase mu-mediated RT cell adhesion."; RL EMBO J. 25:701-712(2006). RN [11] {ECO:0007744|PDB:2V5Y} RP X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 21-742, GLYCOSYLATION AT ASN-72; RP ASN-92; ASN-131; ASN-406; ASN-414; ASN-454 AND ASN-544, SUBCELLULAR RP LOCATION, SUBUNIT, AND MUTAGENESIS OF ARG-239; ARG-240; TYR-297 AND RP TRP-299. RX PubMed=17761881; DOI=10.1126/science.1144646; RA Aricescu A.R., Siebold C., Choudhuri K., Chang V.T., Lu W., Davis S.J., RA van der Merwe P.A., Jones E.Y.; RT "Structure of a tyrosine phosphatase adhesive interaction reveals a spacer- RT clamp mechanism."; RL Science 317:1217-1220(2007). CC -!- FUNCTION: Receptor protein-tyrosine phosphatase that mediates homotypic CC cell-cell interactions and plays a role in adipogenic differentiation CC via modulation of p120 catenin/CTNND1 phosphorylation (PubMed:17761881, CC PubMed:10753936). Promotes CTNND1 dephosphorylation and prevents its CC cytoplasmic localization where it inhibits SLC2A4 membrane trafficking. CC In turn, SLC2A4 is directed to the plasma membrane and performs its CC glucose transporter function (PubMed:21998202). CC {ECO:0000269|PubMed:10753936, ECO:0000269|PubMed:16456543, CC ECO:0000269|PubMed:17761881, ECO:0000269|PubMed:21998202}. CC -!- CATALYTIC ACTIVITY: CC Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] + CC phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA- CC COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858, CC ChEBI:CHEBI:82620; EC=3.1.3.48; CC Evidence={ECO:0000269|PubMed:10753936, ECO:0000269|PubMed:21998202}; CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:17761881}. CC -!- INTERACTION: CC P28827; P28827: PTPRM; NbExp=2; IntAct=EBI-2257317, EBI-2257317; CC P28827; P09803: Cdh1; Xeno; NbExp=3; IntAct=EBI-2257317, EBI-984420; CC -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10753936}; CC Single-pass type I membrane protein. Note=Localizes in regions of cell- CC cell contact. {ECO:0000269|PubMed:10753936}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=P28827-1; Sequence=Displayed; CC Name=2; CC IsoId=P28827-2; Sequence=VSP_046677; CC -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family. CC Receptor class 2B subfamily. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X58288; CAA41226.1; -; mRNA. DR EMBL; AC006566; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP000897; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP001091; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP001094; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP005118; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP005227; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; AP005900; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471113; EAX01623.1; -; Genomic_DNA. DR EMBL; CH471113; EAX01624.1; -; Genomic_DNA. DR EMBL; BC151842; AAI51843.1; -; mRNA. DR CCDS; CCDS11840.1; -. [P28827-1] DR CCDS; CCDS58613.1; -. [P28827-2] DR PIR; S17669; S17669. DR RefSeq; NP_001098714.1; NM_001105244.1. [P28827-2] DR RefSeq; NP_002836.3; NM_002845.3. [P28827-1] DR PDB; 1RPM; X-ray; 2.30 A; A/B=879-1156. DR PDB; 2C9A; X-ray; 2.70 A; A=21-279. DR PDB; 2V5Y; X-ray; 3.10 A; A=21-742. DR PDB; 8A16; X-ray; 2.89 A; A/B=477-723. DR PDB; 8A17; X-ray; 3.09 A; A/B/C/D=477-723. DR PDBsum; 1RPM; -. DR PDBsum; 2C9A; -. DR PDBsum; 2V5Y; -. DR PDBsum; 8A16; -. DR PDBsum; 8A17; -. DR AlphaFoldDB; P28827; -. DR SASBDB; P28827; -. DR SMR; P28827; -. DR BioGRID; 111761; 66. DR DIP; DIP-668N; -. DR IntAct; P28827; 17. DR MINT; P28827; -. DR STRING; 9606.ENSP00000463325; -. DR BindingDB; P28827; -. DR ChEMBL; CHEMBL4661; -. DR GuidetoPHARMACOLOGY; 1860; -. DR DEPOD; PTPRM; -. DR GlyConnect; 1971; 13 N-Linked glycans (6 sites). DR GlyCosmos; P28827; 15 sites, 15 glycans. DR GlyGen; P28827; 15 sites, 14 N-linked glycans (6 sites), 1 O-linked glycan (1 site). DR iPTMnet; P28827; -. DR PhosphoSitePlus; P28827; -. DR SwissPalm; P28827; -. DR BioMuta; PTPRM; -. DR DMDM; 206729890; -. DR EPD; P28827; -. DR jPOST; P28827; -. DR MassIVE; P28827; -. DR MaxQB; P28827; -. DR PaxDb; 9606-ENSP00000463325; -. DR PeptideAtlas; P28827; -. DR ProteomicsDB; 54501; -. [P28827-1] DR Antibodypedia; 21926; 259 antibodies from 34 providers. DR DNASU; 5797; -. DR Ensembl; ENST00000332175.12; ENSP00000331418.8; ENSG00000173482.17. [P28827-1] DR Ensembl; ENST00000580170.6; ENSP00000463325.1; ENSG00000173482.17. [P28827-2] DR GeneID; 5797; -. DR KEGG; hsa:5797; -. DR MANE-Select; ENST00000580170.6; ENSP00000463325.1; NM_001105244.2; NP_001098714.1. [P28827-2] DR UCSC; uc002knn.5; human. [P28827-1] DR AGR; HGNC:9675; -. DR CTD; 5797; -. DR DisGeNET; 5797; -. DR GeneCards; PTPRM; -. DR HGNC; HGNC:9675; PTPRM. DR HPA; ENSG00000173482; Low tissue specificity. DR MIM; 176888; gene. DR neXtProt; NX_P28827; -. DR OpenTargets; ENSG00000173482; -. DR PharmGKB; PA34020; -. DR VEuPathDB; HostDB:ENSG00000173482; -. DR eggNOG; KOG4228; Eukaryota. DR GeneTree; ENSGT00940000155020; -. DR InParanoid; P28827; -. DR OrthoDB; 2875525at2759; -. DR PhylomeDB; P28827; -. DR TreeFam; TF312900; -. DR BRENDA; 3.1.3.48; 2681. DR PathwayCommons; P28827; -. DR SignaLink; P28827; -. DR BioGRID-ORCS; 5797; 20 hits in 1161 CRISPR screens. DR ChiTaRS; PTPRM; human. DR EvolutionaryTrace; P28827; -. DR GeneWiki; PTPRM; -. DR GenomeRNAi; 5797; -. DR Pharos; P28827; Tchem. DR PRO; PR:P28827; -. DR Proteomes; UP000005640; Chromosome 18. DR RNAct; P28827; Protein. DR Bgee; ENSG00000173482; Expressed in ventricular zone and 194 other cell types or tissues. DR ExpressionAtlas; P28827; baseline and differential. DR GO; GO:0005912; C:adherens junction; IDA:UniProtKB. DR GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0043232; C:intracellular non-membrane-bounded organelle; IDA:DisProt. DR GO; GO:0030027; C:lamellipodium; IDA:MGI. DR GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB. DR GO; GO:0005886; C:plasma membrane; IDA:HPA. DR GO; GO:0045296; F:cadherin binding; IDA:UniProtKB. DR GO; GO:0042802; F:identical protein binding; IPI:IntAct. DR GO; GO:0016791; F:phosphatase activity; IDA:UniProt. DR GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB. DR GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; IDA:UniProtKB. DR GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IDA:UniProtKB. DR GO; GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB. DR GO; GO:0010596; P:negative regulation of endothelial cell migration; IMP:UniProtKB. DR GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:UniProtKB. DR GO; GO:0031175; P:neuron projection development; IDA:UniProtKB. DR GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB. DR GO; GO:0009410; P:response to xenobiotic stimulus; IDA:UniProtKB. DR GO; GO:0010842; P:retina layer formation; IMP:UniProtKB. DR GO; GO:0031290; P:retinal ganglion cell axon guidance; IDA:UniProtKB. DR GO; GO:0007165; P:signal transduction; IDA:UniProtKB. DR CDD; cd00063; FN3; 3. DR CDD; cd06263; MAM; 1. DR CDD; cd14633; R-PTPc-M-1; 1. DR CDD; cd14635; R-PTPc-M-2; 1. DR DisProt; DP02580; -. DR Gene3D; 2.60.120.200; -; 1. DR Gene3D; 2.60.40.10; Immunoglobulins; 4. DR Gene3D; 3.90.190.10; Protein tyrosine phosphatase superfamily; 2. DR InterPro; IPR013320; ConA-like_dom_sf. DR InterPro; IPR003961; FN3_dom. DR InterPro; IPR036116; FN3_sf. DR InterPro; IPR007110; Ig-like_dom. DR InterPro; IPR036179; Ig-like_dom_sf. DR InterPro; IPR013783; Ig-like_fold. DR InterPro; IPR003599; Ig_sub. DR InterPro; IPR013151; Immunoglobulin. DR InterPro; IPR000998; MAM_dom. DR InterPro; IPR029021; Prot-tyrosine_phosphatase-like. DR InterPro; IPR000242; PTP_cat. DR InterPro; IPR045911; R-PTP-mu_cat_rpt1. DR InterPro; IPR016130; Tyr_Pase_AS. DR InterPro; IPR003595; Tyr_Pase_cat. DR InterPro; IPR000387; Tyr_Pase_dom. DR PANTHER; PTHR24051:SF12; PROTEIN TYROSINE PHOSPHATASE, RECEPTOR TYPE, M; 1. DR PANTHER; PTHR24051; SUSHI DOMAIN-CONTAINING PROTEIN 1; 1. DR Pfam; PF00041; fn3; 2. DR Pfam; PF00047; ig; 1. DR Pfam; PF00629; MAM; 1. DR Pfam; PF00102; Y_phosphatase; 2. DR PRINTS; PR00020; MAMDOMAIN. DR PRINTS; PR00700; PRTYPHPHTASE. DR SMART; SM00060; FN3; 4. DR SMART; SM00409; IG; 1. DR SMART; SM00137; MAM; 1. DR SMART; SM00194; PTPc; 2. DR SMART; SM00404; PTPc_motif; 2. DR SUPFAM; SSF52799; (Phosphotyrosine protein) phosphatases II; 2. DR SUPFAM; SSF49899; Concanavalin A-like lectins/glucanases; 1. DR SUPFAM; SSF49265; Fibronectin type III; 2. DR SUPFAM; SSF48726; Immunoglobulin; 1. DR PROSITE; PS50853; FN3; 3. DR PROSITE; PS50835; IG_LIKE; 1. DR PROSITE; PS00740; MAM_1; 1. DR PROSITE; PS50060; MAM_2; 1. DR PROSITE; PS00383; TYR_PHOSPHATASE_1; 2. DR PROSITE; PS50056; TYR_PHOSPHATASE_2; 2. DR PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2. DR Genevisible; P28827; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cell adhesion; Cell membrane; KW Disulfide bond; Glycoprotein; Hydrolase; Immunoglobulin domain; Membrane; KW Phosphoprotein; Protein phosphatase; Receptor; Reference proteome; Repeat; KW Signal; Transmembrane; Transmembrane helix. FT SIGNAL 1..20 FT /evidence="ECO:0000255" FT CHAIN 21..1452 FT /note="Receptor-type tyrosine-protein phosphatase mu" FT /id="PRO_0000025448" FT TOPO_DOM 21..742 FT /note="Extracellular" FT /evidence="ECO:0000255" FT TRANSMEM 743..764 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 765..1452 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT DOMAIN 22..184 FT /note="MAM" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00128" FT DOMAIN 186..277 FT /note="Ig-like C2-type" FT DOMAIN 284..379 FT /note="Fibronectin type-III 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 382..480 FT /note="Fibronectin type-III 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 482..587 FT /note="Fibronectin type-III 3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 589..671 FT /note="Fibronectin type-III 4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00316" FT DOMAIN 900..1154 FT /note="Tyrosine-protein phosphatase 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00160" FT DOMAIN 1186..1448 FT /note="Tyrosine-protein phosphatase 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00160" FT ACT_SITE 1095 FT /note="Phosphocysteine intermediate" FT /evidence="ECO:0000250" FT ACT_SITE 1389 FT /note="Phosphocysteine intermediate" FT /evidence="ECO:0000250" FT BINDING 1063 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 1095..1101 FT /ligand="substrate" FT /evidence="ECO:0000250" FT BINDING 1139 FT /ligand="substrate" FT /evidence="ECO:0000250" FT MOD_RES 821 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:18669648" FT CARBOHYD 72 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 92 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 131 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:16335952" FT CARBOHYD 249 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 406 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:17761881, FT ECO:0007744|PDB:2V5Y" FT CARBOHYD 414 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:17761881, FT ECO:0007744|PDB:2V5Y" FT CARBOHYD 454 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:17761881, FT ECO:0007744|PDB:2V5Y" FT CARBOHYD 534 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 544 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000269|PubMed:17761881, FT ECO:0007744|PDB:2V5Y" FT CARBOHYD 598 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 651 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 681 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 27..36 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114, FT ECO:0000269|PubMed:16456543" FT DISULFID 96..182 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114, FT ECO:0000269|PubMed:16456543" FT DISULFID 206..260 FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114, FT ECO:0000269|PubMed:16456543" FT VAR_SEQ 842 FT /note="P -> PDPFVPTAILVPIN (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_046677" FT VARIANT 39 FT /note="S -> R (in dbSNP:rs35224276)" FT /id="VAR_046634" FT MUTAGEN 239 FT /note="R->E: Abolishes dimerization." FT /evidence="ECO:0000269|PubMed:17761881" FT MUTAGEN 240 FT /note="R->E: Abolishes dimerization." FT /evidence="ECO:0000269|PubMed:17761881" FT MUTAGEN 297 FT /note="Y->A: Abolishes dimerization." FT /evidence="ECO:0000269|PubMed:17761881" FT MUTAGEN 299 FT /note="W->A: Abolishes dimerization." FT /evidence="ECO:0000269|PubMed:17761881" FT CONFLICT 3 FT /note="G -> T (in Ref. 1; CAA41226)" FT /evidence="ECO:0000305" FT CONFLICT 68 FT /note="F -> L (in Ref. 1; CAA41226)" FT /evidence="ECO:0000305" FT CONFLICT 1300 FT /note="P -> L (in Ref. 4; AAI51843)" FT /evidence="ECO:0000305" FT CONFLICT 1384 FT /note="R -> P (in Ref. 1; CAA41226)" FT /evidence="ECO:0000305" FT STRAND 29..31 FT /evidence="ECO:0007829|PDB:2C9A" FT HELIX 33..36 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 42..45 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 49..52 FT /evidence="ECO:0007829|PDB:2C9A" FT TURN 53..55 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 66..72 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 81..85 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 96..104 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 106..109 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 111..120 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 129..132 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 140..147 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 155..163 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 169..180 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 183..185 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 194..196 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 198..200 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 202..210 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 217..222 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 230..237 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 240..247 FT /evidence="ECO:0007829|PDB:2C9A" FT HELIX 252..254 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 256..264 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 267..278 FT /evidence="ECO:0007829|PDB:2C9A" FT STRAND 284..286 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 289..293 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 298..301 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 305..309 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 315..326 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 328..332 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 335..340 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 348..356 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 370..373 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 384..391 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 396..401 FT /evidence="ECO:0007829|PDB:2V5Y" FT HELIX 405..408 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 410..412 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 414..434 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 443..446 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 454..462 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 467..469 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 473..476 FT /evidence="ECO:0007829|PDB:2V5Y" FT TURN 487..489 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 491..495 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 498..502 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 515..525 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 536..542 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 547..550 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 557..567 FT /evidence="ECO:0007829|PDB:2V5Y" FT STRAND 570..580 FT /evidence="ECO:0007829|PDB:2V5Y" FT TURN 882..884 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 885..905 FT /evidence="ECO:0007829|PDB:1RPM" FT TURN 916..919 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 921..926 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 936..938 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 939..941 FT /evidence="ECO:0007829|PDB:1RPM" FT TURN 949..952 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 953..961 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 964..971 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 976..978 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 979..988 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 993..996 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 1000..1002 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 1014..1019 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 1022..1032 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 1035..1044 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 1051..1058 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 1063..1065 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 1071..1083 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 1091..1099 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 1100..1118 FT /evidence="ECO:0007829|PDB:1RPM" FT STRAND 1119..1121 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 1123..1133 FT /evidence="ECO:0007829|PDB:1RPM" FT HELIX 1141..1155 FT /evidence="ECO:0007829|PDB:1RPM" SQ SEQUENCE 1452 AA; 163682 MW; 8319E3D3A583E992 CRC64; MRGLGTCLAT LAGLLLTAAG ETFSGGCLFD EPYSTCGYSQ SEGDDFNWEQ VNTLTKPTSD PWMPSGSFML VNASGRPEGQ RAHLLLPQLK ENDTHCIDFH YFVSSKSNSP PGLLNVYVKV NNGPLGNPIW NISGDPTRTW NRAELAISTF WPNFYQVIFE VITSGHQGYL AIDEVKVLGH PCTRTPHFLR IQNVEVNAGQ FATFQCSAIG RTVAGDRLWL QGIDVRDAPL KEIKVTSSRR FIASFNVVNT TKRDAGKYRC MIRTEGGVGI SNYAELVVKE PPVPIAPPQL ASVGATYLWI QLNANSINGD GPIVAREVEY CTASGSWNDR QPVDSTSYKI GHLDPDTEYE ISVLLTRPGE GGTGSPGPAL RTRTKCADPM RGPRKLEVVE VKSRQITIRW EPFGYNVTRC HSYNLTVHYC YQVGGQEQVR EEVSWDTENS HPQHTITNLS PYTNVSVKLI LMNPEGRKES QELIVQTDED LPGAVPTESI QGSTFEEKIF LQWREPTQTY GVITLYEITY KAVSSFDPEI DLSNQSGRVS KLGNETHFLF FGLYPGTTYS FTIRASTAKG FGPPATNQFT TKISAPSMPA YELETPLNQT DNTVTVMLKP AHSRGAPVSV YQIVVEEERP RRTKKTTEIL KCYPVPIHFQ NASLLNSQYY FAAEFPADSL QAAQPFTIGD NKTYNGYWNT PLLPYKSYRI YFQAASRANG ETKIDCVQVA TKGAATPKPV PEPEKQTDHT VKIAGVIAGI LLFVIIFLGV VLVMKKRKLA KKRKETMSST RQEMTVMVNS MDKSYAEQGT NCDEAFSFMD THNLNGRSVS SPSSFTMKTN TLSTSVPNSY YPDETHTMAS DTSSLVQSHT YKKREPADVP YQTGQLHPAI RVADLLQHIT QMKCAEGYGF KEEYESFFEG QSAPWDSAKK DENRMKNRYG NIIAYDHSRV RLQTIEGDTN SDYINGNYID GYHRPNHYIA TQGPMQETIY DFWRMVWHEN TASIIMVTNL VEVGRVKCCK YWPDDTEIYK DIKVTLIETE LLAEYVIRTF AVEKRGVHEI REIRQFHFTG WPDHGVPYHA TGLLGFVRQV KSKSPPSAGP LVVHCSAGAG RTGCFIVIDI MLDMAEREGV VDIYNCVREL RSRRVNMVQT EEQYVFIHDA ILEACLCGDT SVPASQVRSL YYDMNKLDPQ TNSSQIKEEF RTLNMVTPTL RVEDCSIALL PRNHEKNRCM DILPPDRCLP FLITIDGESS NYINAALMDS YKQPSAFIVT QHPLPNTVKD FWRLVLDYHC TSVVMLNDVD PAQLCPQYWP ENGVHRHGPI QVEFVSADLE EDIISRIFRI YNAARPQDGY RMVQQFQFLG WPMYRDTPVS KRSFLKLIRQ VDKWQEEYNG GEGRTVVHCL NGGGRSGTFC AISIVCEMLR HQRTVDVFHA VKTLRNNKPN MVDLLDQYKF CYEVALEYLN SG //